Clinical Trial Update: Safety Study of GL-ONC1, an Oncolytic Virus, in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 safety study of GL-ONC1 in patients with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• GL-ONC1

Snippet

Sponsor: Genelux GmbH | Conditions: Advanced Cancers (Solid Tumors) | Phase 1 | Status: COMPLETED